MedTrace Logo

Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand

NCT05527535 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 34500

Last updated 2022-09-02

No results posted yet for this study

Summary

Efficiency and effectiveness of real-world diabetic retinopathy screening by artificial intelligent (AI) are limited. Investigators will implement AI for diabetic retinopathy screening in 13 health districts in Thailand and investigate the efficiency, effectiveness as well as patients and health care personnel's satisfaction by an implementation research.

Conditions

Interventions

DIAGNOSTIC_TEST

Diabetic retinopathy screening by artificial intelligence

Screening diabetic patients' eyes with AI through digital health platform

DIAGNOSTIC_TEST

Diabetic retinopathy screening by healthcare personnel

Screening diabetic patients' eyes by conventional method (healthcare personnel)

Sponsors & Collaborators

  • Health Systems Research Institute,Thailand

    collaborator OTHER_GOV

  • Department of Medical Services Ministry of Public Health of Thailand

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-03
Primary Completion
2023-03-31
Completion
2023-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05527535 on ClinicalTrials.gov